Colombian Agricultural Institute ("ICA") authorization is a significant requirement to cultivate and distribute medical cannabis in Colombia. Khiron's receipt of the authorization confirms the Company as one of the leading medical cannabis companies in Latin America
TORONTO - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has been registered by the Colombian Agricultural Institute ("ICA") as an agronomical unit. Khiron is one of two companies in Colombia to receive this registration.
As a mandatory requirement for commercializing medical cannabis products in Colombia for distribution, this milestone positions Khiron to receive the first allocation of quota to commence commercial cultivation of high THC strains, and to commence commercial cultivation and production of CBD strains which do not require quota.
Key aspects of the ICA registration include: